Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
株式のランク #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
株価
$240.45
時価総額
$579.46B
変化(1日)
0.51%
変化(1年)
46.88%
US
取引 Johnson & Johnson (JNJ)

カテゴリー

Johnson & Johnson(JNJ)のP/E比率
March 2026 時点のP/E比率 TTM 21.88
Johnson & Johnson の最新の財務報告および株価によると、現在の P/E (TTM) は 21.88 です。2024 年末時点での P/E は 24.53 でした。
Johnson & Johnson の P/E 比率の履歴(2000 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) 21.88 16.71%
2025 18.75 -23.56%
2024 24.53 117.16%
2023 11.30 -47.70%
2022 21.60 -22.85%
2021 28.00 10.67%
2019 25.30 12.64%
2018 22.46 -92.21%
2017 288.31 1,504.75%
2016 17.97 0.04%
2014 17.96 -4.59%
2013 18.82 4.89%
2012 17.95 39.12%
2011 12.90 -11.36%
2010 14.55 15.26%
2008 12.63 -30.55%
2007 18.18 3.55%
2006 17.56 -23.07%
2005 22.82 7.99%
2003 21.14 -13.54%
2002 24.45 -22.65%
2001 31.60 -0.45%
2000 31.75 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
42.86 95.87%
US
92.55 322.93%
US
20.85 -4.72%
CH
28.47 30.08%
GB
15.77 -27.93%
US
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。